title: [Postoperative immunosuppressive therapy for our patients with heart transplantation done in United States].
authors.forename: S
authors.initials: S
authors.lastname: Nunoda
authors.forename: R
authors.initials: R
authors.lastname: Kurosawa
authors.forename: K
authors.initials: K
authors.lastname: Kogashi
authors.forename: A
authors.initials: A
authors.lastname: Kitajima
authors.forename: T
authors.initials: T
authors.lastname: Momose
authors.forename: W
authors.initials: W
authors.lastname: Kajibashi
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D006084:Graft Rejection / Q000517:prevention & control; D016027:Heart Transplantation; D006439:Hemodynamics; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007564:Japan; D016853:Muromonab-CD3 / Q000008:administration & dosage; D011182:Postoperative Care; D011239:Prednisolone / Q000008:administration & dosage; D014481:United States
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine